SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-009160
Filing Date
2021-03-02
Accepted
2021-03-02 20:34:43
Documents
1
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7477
  Complete submission text file 0000899243-21-009160.txt   9133
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Issuer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O FORMA THERAPEUTICS HOLDINGS, INC. 500 ARSENAL STREET, SUITE 100 WATERTOWN MA 02472
Business Address
Potts Jeannette (Reporting) CIK: 0001814693 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39333 | Film No.: 21706648